3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
12
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
HER2-positive Advanced Gastric Cancer
1
HER2 Overexpression
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Esophagectomy
13
Blood Specimen Collection
10
Surgical Procedures, Operative
8
Radiotherapy
8
Surveys and Questionnaires
5
Endoscopic Mucosal Resection
5
Drug Therapy
5
Biopsy
5
Specimen Handling
4
Neoadjuvant Therapy
4
Tissue Banks
3
Psychiatric Rehabilitation
3
Positron Emission Tomography Computed Tomography
3
Polymerase Chain Reaction
3
Observation
3
Magnetic Resonance Spectroscopy
3
Immunotherapy
3
Immunohistochemistry
3
Endoscopy
3
Endoscopic Ultrasound-Guided Fine Needle Aspiration
3
Diffusion Magnetic Resonance Imaging
3
Breath Tests
3
anlotinib
2
Stents
2
Quality of Life
2
Platinum Compounds
2
Paclitaxel
2
Microarray Analysis
2
Mass Screening
2
Gastroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Esophageal Neoplasms
×
trastuzumab deruxtecan
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled